Your browser doesn't support javascript.
loading
Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab.
Yoshida, Terufumi; Miki, Hisanori; Satake, Hironaga; Kobayashi, Toshinori; Matsumi, Yuuki; Hamada, Madoka; Boku, Shogen; Shibata, Nobuhiro; Ishida, Mitsuaki; Sekimoto, Mitsugu.
Affiliation
  • Yoshida T; Department of Surgery, Kansai Medical University Hospital, Hirakata, Japan.
  • Miki H; Department of Surgery, Kansai Medical University Hospital, Hirakata, Japan.
  • Satake H; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan.
  • Kobayashi T; Department of Surgery, Kansai Medical University Hospital, Hirakata, Japan.
  • Matsumi Y; Department of Surgery, Kansai Medical University Hospital, Hirakata, Japan.
  • Hamada M; Department of Surgery, Kansai Medical University Hospital, Hirakata, Japan.
  • Boku S; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan.
  • Shibata N; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan.
  • Ishida M; Department of Pathology and Diagnostics, Kansai Medical University Hospital, Hirakata, Japan.
  • Sekimoto M; Department of Surgery, Kansai Medical University Hospital, Hirakata, Japan.
Case Rep Oncol ; 14(3): 1497-1504, 2021.
Article in En | MEDLINE | ID: mdl-34899242

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2021 Type: Article